Items where Author is "Woodroofe, N."
Number of items: 15.
SCOTT, E., DALEY, A. J., DOLL, H., WOODROOFE, N., COLEMAN, R. E., MUTRIE, N., CRANK, H., POWERS, H. J. and SAXTON, J. M.
(2013).
Effects of an exercise and hypocaloric healthy eating program on biomarkers associated with long-term prognosis after early-stage breast cancer: a randomized controlled trial.
Cancer Causes and Control, 24 (1), 181-191.
[Article]
DHUNGANA, S., WATERS, P., ISMAIL, A., WOODROOFE, N., VINCENT, A. and SHARRACK, B.
(2010).
Absence of aquaporin-4 antibodies in patients with idiopathic intracranial hypertension.
Journal of Neurology, 257 (7), 1211-1212.
[Article]
HADJIVASSILIOU, M., SANDERS, D. S., GRUNEWALD, R. A., WOODROOFE, N., BOSCOLO, S. and AESCHLIMANN, D.
(2010).
Gluten sensitivity: from gut to brain.
The Lancet Neurology, 9 (3), 318-330.
[Article]
DHUNGANA, S., SHARRACK, B. and WOODROOFE, N.
(2010).
Idiopathic intracranial hypertension.
Acta neurologica Scandinavica, 121 (2), 71-82.
[Article]
DHUNGANA, S., SHARRACK, B. and WOODROOFE, N.
(2009).
Cytokines and chemokines in idiopathic intracranial hypertension.
Headache: the journal of head and face pain, 49 (2), 282-285.
[Article]
DHUNGANA, S., SHARRACK, B. and WOODROOFE, N.
(2009).
IL-1β, TNF and IP-10 in the cerebrospinal fluid and serum are not altered in patients with idiopathic intracranial hypertension compared to controls.
Clinical endocrinology, 71 (6), p. 896.
[Article]
HADJIVASSILIOU, M., AESCHLIMANN, P., STRIGUN, A., SANDERS, D. S., WOODROOFE, N. and AESCHLIMANN, D.
(2008).
Autoantibodies in gluten ataxia recognize a novel neuronal transglutaminase.
Annals of neurology, 64 (3), 332-343.
[Article]
HADJIVASSILIOU, M., BOSCOLO, S., TONGIORGI, E., GRÜNEWALD, R. A., SHARRACK, B., SANDERS, D. S., WOODROOFE, N. and DAVIES-JONES, G. A. B.
(2008).
Cerebellar ataxia as a possible organ-specific autoimmune disease.
Movement disorders, 23 (10), 1370-1377.
[Article]
HADJIVASSILIOU, M., SANDERS, D. S., WOODROOFE, N., WILLIAMSON, C. and GRÜNEWALD, R. A.
(2008).
Gluten ataxia.
The Cerebellum, 7 (3), 494-498.
[Article]
CROSS, A. K., HADDOCK, G., STOCK, C. J., ALLAN, S., SURR, J., BUNNING, R. A., BUTTLE, D. J. and WOODROOFE, N.
(2006).
ADAMTS -1 and -4 are up-regulated following transient middle cerebral artery occlusion in the rat and their expression is modulated by TNF in cultured astrocytes.
Brain research, 1088 (1), 19-30.
[Article]
SAXTON, J. M., DALEY, A., WOODROOFE, N., COLEMAN, R., POWERS, H., MUTRIE, N., SIDDALL, V. and CRANK, H.
(2006).
Study protocol to investigate the effect of a lifestyle intervention on body weight, psychological health status and risk factors associated with disease recurrence in women recovering from breast cancer treatment.
BMC cancer, 6.
[Article]
CROSS, A. K., HADDOCK, G., SURR, J., PLUMB, J., BUTTLE, D. J. and WOODROOFE, N.
(2005).
Differential expression of ADAMTS -1, -4, -5 and TIMP -3 in rat spinal cord at different stages of acute experimental autoimmune encephalomyelitis.
Journal of autoimmunity, 26 (1), 16-23.
[Article]
MAHAD, D. J., HOWELL, S. J. L. and WOODROOFE, N.
(2002).
Expression of chemokines in cerebrospinal fluid and serum of patients with chronic inflammatory demyelinating polyneuropathy.
Journal of neurology neurosurgery and psychiatry, 73 (3), 320-323.
[Article]
KIESEIER, B. C., TANI, M., MAHAD, D., OKA, N., HO, T., WOODROOFE, N., GRIFFIN, J. W., TOYKA, K. V., RANSOHOFF, R. M. and HARTUNG, H-P.
(2001).
Chemokines and chemokine receptors in inflammatory demyelinating neuropathies: a central role for IP-10.
Brain, 125 (4), 823-834.
[Article]
JOHN, G. R., SIMPSON, J. E., WOODROOFE, N., LEE, S. C. and BROSNAN, C. F.
(2001).
Extracellular nucleotides differentially regulate interleukin-1 signaling in primary human astrocytes: implications for inflammatory gene expression.
Journal of Neuroscience, 21 (12), 4134-4142.
[Article]